{"slug":"wuxi-biologics","name":"우시바이오로직스(약명생물)","name_en":"WuXi Biologics","ticker":"2269.HK","updated_at":"2026-07-11T10:21:36.482+00:00","canonical":"https://valuechain.wiki/wuxi-biologics","kicker":"항셍 지수","kicker_en":"Hang Seng Index","lead":"세계적 바이오의약품 위탁개발·생산(CDMO) 기업으로 항체 등 바이오 신약의 개발과 생산을 대행한다. 항셍 지수 구성종목. 밸류체인 관계·수치 데이터는 조사 전인 기본 노드로, AI 질문 수요가 관측되면 상세 노드로 승격된다.","lead_en":"A global biologics CDMO providing development and manufacturing for antibody and other biopharmaceutical drugs. Hang Seng Index constituent. Baseline node ahead of value-chain research; promoted to a full node once AI question demand is observed.","segments":{"parts":[{"name":"IND 이전(초기개발)"},{"name":"IND 이후(후기·상업생산)"}],"total":"약 ¥170억 (FY2023)"},"segments_en":{"parts":[{"name":"Pre-IND (early development)"},{"name":"Post-IND (late-stage & commercial)"}],"total":"approx. CN¥17.0B (FY2023)"},"returns_yearly":{"2021":-30.7,"2022":-13.7,"2023":-68.6,"2024":-10.1,"2025":100.9,"2026":2.6},"return_asof":"2026-07-10","value_chain":{"leading":[],"benefiting":[],"analysis":null,"analysis_en":null,"analysis_asof":null},"edges":[]}